Investing Profile

Tim Shannon


General Partner at Canaan Partners, Connecticut
Photo of Tim Shannon, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Canaan Partners General Partner
$250K - $20.0M
CompanyStageDateRound SizeTotal Raised
Series AApr 2018$37M
Vivace Therapeutics
Series BJun 2017$25M
IDEAYA Biosciences
Series AMay 2016$46M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Thilo Schroeder (Nextech Invest)
Series AJan 2016$67M
Co-investors: Colleen Cuffaro (Canaan Partners)
Series BOct 2015$41.6M
Series ASep 2013$15M
Co-investors: Jakob Loven (Nextech Invest), Kush Parmar (5am Ventures), Daniel Wagner (Connecticut Innovations), Colleen Cuffaro (Canaan Partners), Stephen Squinto (OrbiMed)
Spyryx Biosciences
Series AMay 2015$18.2M
Co-investors: Christy Shaffer (Hatteras Venture Partners), Brian Daniels (5am Ventures)
CytomX Therapeutics
Series CJan 2015$20M
Co-investors: Neil Exter (Third Rock Ventures), Charles Homcy (Third Rock Ventures)
Civitas Therapeutics
Series CAug 2014$55M
Series BSep 2013$38M